ARTICLE | Clinical News
Ruconest conestat alfa: Completed Phase II enrollment
February 8, 2016 8:00 AM UTC
Pharming completed enrollment of 30 patients deficient in C1 esterase inhibitor with a history of >=4 attacks per month in a double-blind, placebo-controlled, 3-period crossover, international Phase I...